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Abstract
To date, minimal research has investigated the effect of combining dexamphetamine with standard naming therapy
after stroke. The present study used a double-blind, placebo-controlled, multiple baseline, crossover design with two
individuals in the chronic stage of stroke recovery. Each individual attended two 4-week blocks of naming therapy
(two to three treatment sessions per week). Dexamphetamine (10 mg) was administered at the start of each session
during one therapy block, while a placebo was administered during the other therapy block. Therapy progress on
treated and untreated items was assessed by a confrontation naming task during and after each therapy block. Both
individuals showed greater progress in therapy and maintenance of therapy gains when behavioral treatment was
combined with dexamphetamine rather than placebo, although this gain was only statistically significant in one
individual. There was no significant improvement on a control task (nonword reading) in either individual. The
results provide preliminary evidence that dexamphetamine paired with combined semantic and phonological therapy
may be beneficial for the treatment of naming disorders in chronic aphasia. (JINS, 2007, 13, 972–979.)
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INTRODUCTION
Previous research has found that dexamphetamine can
improve general speech0 language recovery in the acute
recovery stage after stroke in a nonblinded single case study
(Walker-Batson et al., 1990) and in a nonblinded case series
study with six participants (Walker-Batson et al., 1992).
However, the significance of these results is difficult to
gauge, given the open label (nonblinded) nature of the stud-
ies. Nonetheless, a more recent double-blind, placebo-
controlled study by Walker-Batson and colleagues (2001)
also found that dexamphetamine improved general acute-
stage speech0language recovery compared with a placebo.
To date, few studies have specifically investigated the
effects of dexamphetamine on word retrieval therapy. McNeil
et al. (1997) found that dexamphetamine did not improve
naming beyond the level achieved with behavioral therapy
(therapy involved synonym and antonym generation) in an
individual with chronic aphasia poststroke. It is important
to note that the participant was 3 years poststroke. The time
frame during which dexamphetamine may assist functional
recovery poststroke remains unknown (de Boissezon et al.,
2007; Knecht et al., 2001; Nadeau & Wu, 2006; Shisler
et al., 2000; Walker-Batson et al., 2004), however, it has
been argued that it may be more effective in the acute recov-
ery stage (de Boissezon et al., 2007; Walker-Batson et al.,
2004), thus the participant may have been at a recovery
stage where dexamphetamine was of little benefit. The find-
ing by McNeil et al. (1997) that naming improved only
when the participant received behavioral therapy, but not
the drug alone, is consistent with data suggesting that dex-
amphetamine is most effective when administered in con-
junction with behavioral therapy designed specifically to
target the neurological impairment (Crisostomo et al., 1988;
Long & Young, 2003; Martinsson & Eksborg, 2004; Nadeau
& Wu, 2006; Nudo et al., 2001; Walker-Batson et al., 1995).
Of interest, research with healthy adults has also found that
dexamphetamine paired with task-specific training can sig-
nificantly facilitate normal behavioral learning mecha-
nisms (e.g., Breitenstein et al., 2004; Nadeau & Wu, 2006;
Soetens et al., 1995; Whiting et al., 2007a,b).
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In summary, evidence suggests that pharmacological
agents may be beneficial during aphasia therapy. However,
exactly which pharmacological agents and which aphasia
symptoms and treatment tasks are most responsive to phar-
macological intervention remains unknown. The present
study aimed to investigate the effects of combining dex-
amphetamine with a current behavioral naming therapy
approach (e.g., Drew & Thompson, 1999; Nettleton & Lesser,
1991). The present study was more constrained than previ-
ous studies (e.g., Walker-Batson et al., 1990, 1992, 2001) in
that it was limited to individuals with anomic aphasia, ther-
apy tasks were limited to noun retrieval only, a set amount
of therapy was provided, and item-specific outcome mea-
sures were used to determine the specificity of treatment
effects. In this study, we tested the adjuvant effects of dex-
amphetamine in chronic stroke patients, with the effects
likely to be mediated through the potentiation of normal
learning mechanisms. In contrast, prior studies (Walker-
Batson et al., 1990, 1992, 2001) tested the potential adju-
vant effects of dexamphetamine in individuals with subacute
stroke, in which the effects of dexamphetamine were likely
mediated through the potentiation of spontaneous reactive
neuroplasticity. The analysis of our results was facilitated
by the fact that, in contrast to participants in subacute stud-
ies, our participants were no longer experiencing spontane-
ous recovery.
METHODS
Participants
Two right-handed, monolingual English speaking individ-
uals with aphasia (P1 and P2) were recruited to participate
in the study. Inclusion criteria included (a) a single stroke at
least 6 months previously, and (b) vision (with or without
corrective devices), hearing, and body weight within nor-
mal limits. Exclusion criteria included (a) any psychiatric,
other neurological, or degenerative disorders0diseases;
(b) obstructive sleep apnea; (c) a history of substance abuse;
(d) significant motor speech disorders; (e) currently re-
ceiving a-adrenergic antagonist or agonist medication,
antidepressants, or tranquillizers; or (f ) regular cigarette
smoking.
To determine the locus of each participant’s naming dif-
ficulties, participants completed the Boston Naming Test
(BNT; Kaplan et al., 1983), the Comprehensive Aphasia
Test (CAT; Swinburn et al., 2004), and selected subtests
from the Psycholinguistic Assessment of Language Process-
ing in Aphasia (PALPA; Kay et al., 1992; see Tables 1 and
2). The BNT was administered to estimate the severity of
each participant’s naming difficulties and to gauge the effec-
tiveness of phonemic cues. The CAT was administered to
provide an overall profile of the functioning of the different
components of the single word processing model (e.g., Pat-
terson & Shewell, 1987) for each participant. The PALPA
auditory synonym judgment task, auditory lexical decision,
nonword repetition, and nonword reading tasks were admin-
istered to evaluate the functioning of each participant’s
semantic system, phonological input lexicon, auditory-
to-phonological conversion route, and orthographic-to-
phonological conversion route.
P1 was a 76-year-old, right-handed, retired female farmer
with 15 years of education. P1 was admitted to hospital in
May 2001 with an acute right basal ganglia infarct in the
branches of the right middle cerebral artery. As P1 was
right-handed and had experienced a right-sided stroke, the
presence of a crossed aphasia was suggested (Raymer et al.,
2001). Upon entering the present study, P1’s language pro-
duction was fluent. P1’s errors on the BNT at this time
consisted predominantly of no responses and semantic errors,
with some circumlocutory responses (see Table 1). Phone-
mic cues were of little use, with only 3030 phonemic cues
being effective. The locus of P1’s naming difficulties was
analyzed in terms of a single word processing model (Pat-
terson & Shewell, 1987). As language assessments found
that (a) P1’s naming difficulties were susceptible to image-
ability, (b) her semantic memory and comprehension of
words was compromised, and (c) semantic distractors were
the predominant error type in spoken and written naming,
impairment at the conceptual–semantic level was probable
(Cole-Virtue & Nickels, 2004; Howard & Gatehouse, 2006;
Nickels, 2001; Whitworth et al., 2005). Frequency effects
on an auditory lexical decision task suggested that there
Table 1. Participant BNT and PALPA assessment scores during
the pretreatment sessions
Assessment P1 P2
BNT 30060* 25060*
Correct responses with phonemic cueing 3030 19034
PALPA Auditory synonym judgments
High imageability 24030* 27030*
Low imageability 15030* 23030*
PALPA auditory lexical decision
High imageability High frequency 20020 20020
High imageability Low frequency 20020 19020*
Low imageability High frequency 18020* 20020
Low imageability Low frequency 16020* 19020a
PALPA Nonword repetitionb
1 syllable 3010 9010
2 syllable 7010 8010
3 syllable 9010 9010
PALPA Nonword reading
3 letter 606 506a
4 letter 606 406*
5 letter 606 406*
6 letter 506 206*
Note. BNT5Boston Naming Test (Kaplan et al., 1983); PALPA, Psycho-
linguistic Assessment of Language Processing in Aphasia (Kay et al.,
1992).
aBorderline between intact and impaired functioning;
bNo norms available. Norms were obtained from individual test manuals
referenced above.
*Below the cutoff for intact functioning.
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may have been additional impairments in the phonological
input lexicon (see Tables 1 and 2 for more information).
Similarly, frequency effects in spoken naming and better
performance on the PALPA auditory synonym judgment
task compared with the BNT suggested that there may have
been further impairments in the representation of lexical
items within the phonological output lexicon or in the access
to the lexical items from the semantic system (Nickels,
2001; Whitworth et al., 2005).
P2 was a 68-year-old, female, retired high school drama
teacher with 15 years of education. P2 presented at hospital
in June 2004 with a left embolic stroke involving the mid-
dle cerebral artery. At the time of the present study, P2’s
language production was fluent. P2’s errors on the BNT at
this time consisted primarily of no responses. Phonemic
cues were of some benefit, with 19034 phonemic cues being
effective (see Table 1). Language assessments indicated that
P2 experienced greater difficulty naming verbs compared
with nouns, although both were impaired. P2’s perfor-
mance on an auditory lexical decision task suggested that
her phonological input lexicon was intact (Kay et al., 1992).
The presence of imageability effects on the auditory syn-
onym judgment task, but good performance on the seman-
tic memory and word comprehension tasks suggested a mild
impairment at the lexical–semantic level (Cole-Virtue &
Nickels, 2004; Howard & Gatehouse, 2006). Additionally,
the representation of items within P2’s phonological output
lexicon or the link between the semantic system and the
phonological output lexicon may have been impaired as (a)
phonemic cues facilitated naming, (b) P2’s naming was sen-
sitive to word frequency, (c) P2’s spoken naming was poorer
than her written naming, (d) P2’s performance on the BNT
was poorer than expected based on her performance on the
auditory synonym judgment task, and (e) circumlocutions
were present in P2’s naming errors (Howard & Gatehouse,
2006; Nickels, 2001; Whitworth et al., 2005; see Tables 1
and 2 for more information).
Before inclusion in the study, P1 and P2 completed a
medical examination (including a blood test and an electro-
cardiogram) with a general practitioner. In addition, they
were given a trial dose of dexamphetamine and monitored
for side effects, none of which occurred. Both participants
had previously received treatment for anomia; however, they
did not receive any anomia treatment from outside sources
while participating in study. Both P1 and P2 provided writ-
ten consent for participation in study.
Experimental Stimuli
The experimental stimuli consisted of black-and-white line
drawings of real objects from Snodgrass and Vanderwart
(1980), the International Picture-Naming Project (Szekely
et al., 2004), and An Object and Action Naming Battery
(Druks & Masterson, 2000). The names ranged from one to
four syllables, and represented a combination of low,
medium, and high frequency words.
Experimental Procedure
The study was conducted in accordance with the Declara-
tion of Helsinki. Ethical clearance was obtained from the
University of Queensland Medical Research Ethics Com-
mittee, the Queensland Health Human Research Ethics Com-
mittee, and the Human Research Ethics Committees of
individual hospitals.
Pretreatment procedures
Each participant attended three pretreatment sessions. Dur-
ing the pretreatment sessions, participants completed a bat-
tery of language and neuropsychological assessments (see
Tables 1 and 2) and attempted to name the experimental
stimuli. Each participant attempted to name the stimuli (403
items for P1 and 300 items for P2) on two separate occa-
Table 2. Participant CAT assessment scores during the
pretreatment sessions
Subtest P1 P2
Cognitive screen
Line bisection 0 21.5
Semantic memory 7010* 10010
Word fluency 8* 8*
Recognition memory 6010* 10010
Gesture object use 11012 12012
Arithmetic 406 406
Language comprehension
Spoken words 28030 30030
Spoken sentences 26032* 29032
Spoken paragraphs 304 304
Written words 25030* 29030
Written sentences 23032a 28032
Expressive language
Repetition
Words 30032 30032
Complex words 406* 506a
Nonwords 6010 8010
Digit string span 6 6
Sentences 12012 12012
Naming
Objects 37048* 28048*
Actions 10010 4010*
Reading
Words 46048 44048*
Complex words 406a 606
Function words 606 606
Nonwords 10010 6010a
Writing
Copying 10027* 27027
Picture names 20021 14021*
Dictation 27028 27028
Note. CAT5 Comprehensive Aphasia Test (Swinburn et al., 2004).
aBorderline between intact and impaired functioning. Norms were obtained
from the CAT manual (Swinburn et al., 2004).
*Below the cutoff for intact functioning.
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sions (P1 was required to name extra items so that suffi-
cient items were available for use as treatment items). The
stimuli were presented one-by-one on a laptop computer. A
response was scored as correct if the name of the object was
produced within 5 seconds. As per previous studies (e.g.,
Drew & Thompson, 1999; Howard et al., 1985a), responses
where a single phoneme was added, substituted, distorted,
or omitted were scored as correct. All other responses were
scored as incorrect.
Based upon individual pretreatment performance, exper-
imental items were selected to use as treatment stimuli for
each participant (140 for P1 and 124 for P2). The items
were divided into the following conditions for P1: Set A [30
incorrectly named pictures, 30 incorrectly named control
pictures, and 10 correctly named pictures (total n 5 70)]
and Set B [30 incorrectly named pictures, 30 incorrectly
named control pictures, and 10 correctly named pictures
(total n 5 70)]. For P2, the items were divided into the
following conditions: Set A [31 incorrectly named pictures
and 31 incorrectly named control pictures (total n 5 62)]
and Set B [31 incorrectly named pictures and 31 incorrectly
named control pictures (total n 5 62)]. Within and across
each set, the treated and untreated (control) pictures were
matched for frequency (Francis & Kucera, 1982) (where
available), word length, and number of syllables (all p .
.10). During the pretreatment sessions, participants also com-
pleted a control task (nonword reading) on two separate
occasions.
Treatment Procedures
Participants attended two 4-week blocks of morning ther-
apy sessions (two to three sessions per week) for a total of
10 sessions per block. While we acknowledge that Bhogal
and colleagues (2003) recommended that individuals with
aphasia should receive an intense block of therapy (approx-
imately 8.8 hours of therapy per week for 11.2 weeks), we
designed our study to reflect current therapy practice for
individuals who are in the chronic recovery stage post-
stroke. The therapy blocks were separated by a 4-week
washout period during which no anomia therapy or dexam-
phetamine was received. Each participant received two 5-mg
dexamphetamine tablets during one therapy block and two
matched placebo tablets during the other therapy block. Par-
ticipants were given the tablets by a nurse approximately
1.75 hours before commencing the therapy tasks each ses-
sion. This time period was selected so that optimal dexam-
phetamine plasma levels were reached during the therapy
tasks (Angrist et al., 1987; Asghar et al., 2003). The partici-
pants and the speech pathologist running the sessions were
blinded as to whether the participants received the dexam-
phetamine or placebo each session.
The therapy component of each session lasted approxi-
mately 45 minutes. As per previous research (e.g., Drew &
Thompson, 1999; Nettleton & Lesser, 1991; Nickels, 2002),
we decided to use a multimodal approach to treatment to
address the different levels of breakdown. Participants com-
pleted a pseudorandomized selection of computer-based ther-
apy tasks each session from a battery of tasks, including (a)
word-picture matching (participants pointed to the picture
that matched a spoken word from a choice of four pictures
and then repeated the word), (b) yes0no semantic judg-
ments (participants responded yes0no to questions about
the semantic features of items, e.g., is a fork used for eat-
ing?), (c) naming with a phonemic cue (participants named
pictures of objects when verbally given the first sound in
the word), (d) word repetition (participants repeated the
name of an item when presented with a picture of the item
and a verbal model), (e) counting syllables and phonemes
(participants counted the number of sounds or syllables in
words when given a picture of the item and the spoken
name), and (f ) re-arranging anagrams (participants re-
arranged letters to spell the item names when given a pic-
ture of each item and scrambled letters in the item’s name).
Participants were corrected for errors during the tasks. Each
participant completed each therapy task the same number
of times in blocks one and two. Participants completed three
tasks each session with all of the items within one set of
stimulus items (A or B). For each participant, the stimulus
items in Set A were treated during one therapy block and
the stimulus items in Set B were treated during the other
block. The order of the therapy tasks and the order of the
stimuli for each task were randomized each session. All
therapy tasks were presented using E-prime experimental
software (Psychology Software Tools, Pittsburgh, PA).
At the start of every third therapy session, participants
were tested on all the pictures within the set being targeted
during that therapy block (treated and untreated). For a
response to be correct, the object had to be named within 5
seconds. Where participants offered multiple answers, only
the first answer was scored. Participants were re-assessed
with both Sets A and B in their entirety at the end of the
washout period and at the end of the second therapy block.
The control task was completed at the same time as the
naming probes. Different matched sets of nonwords were
used in blocks one and two.
Posttreatment Procedures
Participants were re-assessed with each set 1 day and 1
month after completing each therapy block. The control
nonnaming task (nonword reading) was also completed dur-
ing these sessions.
Data Analysis
For both participants, the proportion of correct responses
on the naming and nonword reading tasks was analyzed
using Z tests, as per Zou et al. (2003) and Bordens and
Abbott (1991). As per previous research, for data pertain-
ing to naming accuracy, only items that were named incor-
rectly during the baseline sessions were included in the
analyses (e.g., Best et al., 2002; Howard et al., 1985b; Miceli
et al., 1996). An a level of .05 was used for all analyses.
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The physiological measures blood pressure and heart rate
were analyzed descriptively by calculating means and stan-
dard deviations.
RESULTS
P1
Naming
By the end of each therapy block, P1 correctly named treated
items under dexamphetamine more accurately than items
treated under placebo, however, the difference was not sta-
tistically significant ( p. .05; see Figure 1). The difference
was still present 1 month later, but remained statistically
nonsignificant (see Figure 1). Treated items were named
more accurately than untreated items by the end of both
therapy blocks (Dexamphetamine: Z 5 4.886, p , .001;
Placebo: Z 5 3.319, p , .001), with the difference still
present 1 month later (see Figure 1). There was no differ-
ence between dexamphetamine or placebo untreated items
at the end of the therapy blocks ( p. .05).
Control task
For P1, there was no significant difference in the number of
nonwords read correctly under dexamphetamine compared
with placebo at baseline, during the probe sessions, or at
follow-up ( p . .05). Within each therapy block, the num-
ber of nonwords read correctly by P1 did not change sig-
nificantly between the baseline, probe, and follow-up
sessions (all p. .05).
Physiological measures
Overall, P1’s blood pressure (systolic and diastolic) increased
marginally between baseline and the start of the therapy
tasks under dexamphetamine, but decreased marginally under
placebo (see Table 3). P1’s heart rate increased slightly under
dexamphetamine and placebo, with a slightly greater increase
occurring under dexamphetamine (see Table 3).
Fig. 1. Percentage of items named correctly by P1 under dexamphetamine and placebo. DEX, Dexamphetamine; PLC,
placebo; T, treated; U, untreated; B, baseline; P, probe; FO, follow-up.
Table 3. Average blood pressure and heart rate measurements during each therapy session
Pre-tablet Pre-therapy (1.75 hours later)
Participant BPs BPd HR BPs BPd HR
P1 DEX 132.00 (5.87) 62.00 (3.50) 66.00 (5.73) 134.50 (7.62) 63.50 (7.47) 69.40 (5.17)
PLC 124.00 (10.75) 64.50 (8.96) 66.80 (6.88) 121.20 (6.14) 62.00 (5.87) 67.20 (10.51)
P2 DEX 110.00 (8.50) 68.50 (7.47) 59.60 (8.93) 104.00 (9.94) 67.00 (6.32) 67.40 (6.40)
PLC 98.50 (6.69) 59.50 (4.97) 62.00 (6.99) 97.00 (3.50) 60.50 (1.58) 62.60 (8.59)
Note. DEX 5 dexamphetamine; PLC 5 placebo; BPs 5 systolic blood pressure; BPd 5 diastolic blood pressure; HR 5 heart rate.
Standard deviations are provided in brackets.
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P2
Naming
By the end of each therapy block, P2 correctly named treated
items under dexamphetamine more accurately than items
treated under placebo (Z 5 1.523; p 5 .032), with the dif-
ference still present 1 month later (see Figure 2). Treated
items were named more accurately than untreated items by
the end of both therapy blocks (Dexamphetamine: Z55.627,
p, .001; Placebo: Z5 4.917; p, .001), with the difference
still present 1 month later (see Figure 2). There was no
difference between dexamphetamine or placebo untreated
items at the end of the therapy blocks ( p. .05).
Control task
There was no significant difference in the number of non-
words read correctly by P2 under dexamphetamine com-
pared with placebo at baseline, during the probe sessions,
or at follow-up ( p . .05). Within each therapy block, the
number of nonwords read correctly by P2 did not change
significantly between the baseline, probe, and follow-up
sessions (all p. .05).
Physiological measures
Under dexamphetamine, P2’s blood pressure (systolic and
diastolic) decreased slightly between baseline and the start
of the therapy tasks. Under placebo, P2’s systolic blood
pressure also decreased during this time; however, her dia-
stolic blood pressure increased marginally (see Table 3).
P2’s heart rate increased under dexamphetamine but not
under placebo (see Table 3).
DISCUSSION
The present study suggests that dexamphetamine might
improve language treatment effects in some individuals with
chronic aphasia. This finding contrasts with research which
has suggested that dexamphetamine can enhance language
recovery in the acute stage poststroke (Walker-Batson et al.,
1992, 2001), but not in the chronic recovery stage (McNeil
et al., 1997; Walker-Batson et al., 2004), a phenomenon
that has been attributed to the drug’s neuromodulatory effects
on brain plasticity during the early recovery stage (de Bois-
sezon et al., 2007; Walker-Batson et al., 2004). Thus, the
present study suggests that combined dexamphetamine and
behavioral therapy may be of benefit for some individuals
who have reached a plateau in traditional behavioral ther-
apy, but still experience stroke-related naming difficulties.
As discussed previously, Nadeau and Wu (2006) sug-
gested that dexamphetamine may act as an adjuvant to
enhance treatment effects when rehabilitation involves nor-
mal learning processes; however, the exact mechanisms
through which this occurs are unknown. That P1 and P2 did
not improve significantly on the control task (nonword read-
ing) suggests that the effects of dexamphetamine were not
due to a generalized improvement in language function-
ing and were specific to learning. That dexamphetamine
appeared to improve treated but not untreated items pro-
vided further suggestion for a role for dexamphetamine in
the re-learning of specific lexical items. Indeed, research
with healthy adults has found that dexamphetamine can
improve new word learning and later retrieval (Breitenstein
et al., 2004; Whiting et al., 2007a,b). It is possible that
dexamphetamine may have acted by improving attentional
mechanisms or consolidation of the items within long-term
memory (Soetens et al., 1993, 1995; Stefanatos et al., 2006);
however, further research is required. Similarly, it is not
possible to dissociate the precise neurophysiological basis
for the observed effects (See Breitenstein et al., 2004; Knecht
et al., 2004 for a more detailed discussion of this issue).
Unfortunately we were not able to measure the generaliza-
tion of treatment effects to everyday living; however, this
should be a direction for future research.
Fig. 2. Percentage of items named correctly by P2 under dexamphetamine and placebo. DEX, Dexamphetamine; PLC,
placebo; T, treated; U, untreated; B, baseline; P, probe; FO, follow-up.
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The statistical test of proportions used in our study (Zou
et al., 2003) is normally used to test proportions involving
populations of individuals, in which one can safely assume
lack of statistical interdependence among the treated items
(individual subjects) with respect to drug effect. In the present
study, the individual items were words and lack of statisti-
cal interdependence with respect to drug effect cannot be
assured.
As a final note, neither P1 nor P2 experienced adverse
effects from dexamphetamine. It is important to note that
P2 reached ceiling levels (i.e., 100% items named cor-
rectly) at the completion of the therapy under dexamphet-
amine. Thus, if more items were included in the naming
battery, it is possible that P2 may have displayed an even
greater improvement on items treated under dexamphet-
amine compared with placebo. As the present study con-
sisted of two case studies and only modest treatment effects
were observed, further research involving a greater number
of participants is warranted. Further research is also required
to systematically compare whether dexamphetamine is more
effective as an adjunct to behavioral naming therapy in the
acute or chronic recovery stages poststroke and to investi-
gate which symptoms and treatments are most responsive
to pharmacotherapy.
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